AddLife reports Q3 2026 sales growth
Net sales rose 7% to SEK 2,599m. EBITA margin improved to 11.5%. The company completed acquisitions of Unicam and Lehnen while decentralizing operations.
See the latest news and media coverage for AddLife. We track all announcements, press releases, and industry mentions in real time, all in one place.
European life science company group
add.lifeLast updated
In short: AddLife reported 7% Q3 sales growth, higher profit, and acquired Lehnen and Unicam
Net sales rose 7% to SEK 2,599m. EBITA margin improved to 11.5%. The company completed acquisitions of Unicam and Lehnen while decentralizing operations.
Net sales increased 6% and EBITA margin reached 12.6%, driven by organic momentum and acquisitions. Profit before tax rose 29%, while cash flow remained strong.
Report shows high margins, increased acquisitions, and positive trends. Video conference airs at 09.00 CET.
The company achieved a 12.5% EBITA margin and completed BioSpectrum and CoaChrom acquisitions while maintaining strong cash conversion.
AddLife AB (FRA:1AD1) delivered 7% sales growth with adjusted EBITDA up 11% and a strengthened 11.5% margin, while accelerating acquisitions and posting operating cash flow...
AddLife AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported sales...
Medical technology company Addlife reports an adjusted EBITA result of 298 million kronor for the third quarter of 2026 (270).
AddLife AB ser. B (ALIF_B.ST) reported a profit for its third quarter that Increased, from last year The company's bottom line came in at SEK127...
Track AddLife and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to AddLife and other trending companies.